HS-001

N/A

Report date: 2024/08/01 16:14:53

Base Information

Drug NameHS-001

Drug Alias NameHS-001HS-001 Human (allogeneic) iPS-cell-derived cardiomyocyte spheroidsNN-9003NN9003

ClassificationCell and gene therapy > Cell therapy > Donor > AllogeneicCell and gene therapy > Cell therapy > Source of cells > iPSC-derivedCell and gene therapy > Cell therapy > Somatic cell > Myocardium therapy

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsMyocardial IschemiaHeart Failure

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesHeartseed Inc

China Registration ClassN/A

Develop Information

Active CompaniesHeartseed Inc Novo Nordisk A/S

Inactive CompaniesN/A

Active IndicationsMyocardial IschemiaHeart Failure

Inactive IndicationsN/A

Other Information

ATC CodeN/A